AbbVie Biotherapeutics Inc.;Dana-Farber Cancer Institute, Inc.
发明人:
AFAR DANIEL,ANDERSEN KENNETH C.,TAI YU-TZU
申请号：
PL13168383
公开号：
PL2641601T3
申请日:
2007.08.07
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
Composition suitable for treating multiple myeloma in a subject, comprising a therapeutically effective amount of HuLuc63, a therapeutically effective amount of bortezomib, and a pharmaceutically acceptable carrier, wherein said composition is capable of being administered in a single or multiple dose regimen.
